Golovaty, ISharma, MVan Heerden, Avan Rooyen, HBaeten, J.MCelum, CBarnabas, R.V2024-08-202024-08-202018-08-15Golovaty I, Sharma M, Van Heerden A, van Rooyen H, Baeten JM, Celum C, Barnabas RV. Cost of Integrating Noncommunicable Disease Screening Into Home-Based HIV Testing and Counseling in South Africa. J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):522-526. doi: 10.1097/QAI.0000000000001713.10.1097/QAI.000000000000171310.1097/QAI.0000000000001713https://pubmed.ncbi.nlm.nih.gov/29771779/https://hdl.handle.net/11288/597317Introduction: Integrated HIV-noncommunicable disease (NCD) services have the potential to avert death and disability but require data on program costs to assess the impact of integrated services on affordability. Methods: We estimated the incremental costs of NCD screening as part of home-based HIV testing and counseling (HTC) and referral to care in KwaZulu-Natal, South Africa. All adults in the households were offered integrated HIV-NCD screening (for HIV, diabetes, hypertension, hypercholesterolemia, obesity, depression, tobacco, and alcohol use), counseling, and linkage to care. We conducted comprehensive program microcosting including ingredient-based and activity-based costing, staff interviews, and time assessment studies. Sensitivity analyses varied cost inputs and screening efficiency. Results: Integrating all-inclusive NCD screening as part of home-based HTC in a high HIV prevalence setting increased program costs by $3.95 (42%) per person screened (from $9.36 to $13.31 per person). Integrated NCD screening, excluding point-of-care cholesterol testing, increased program costs by $2.24 (24%). Furthermore, NCD screening integrated into HTC services reduced the number of persons tested by 15%-20% per day. Conclusions: Integrated HIV-NCD screening has the potential to efficiently use resources compared with stand-alone services. Although all-inclusive NCD screening could increase the incremental cost per person screened for integrated HIV-NCD services over 40%, a less costly lipid assay or targeted screening would result in a modest increase in costs with the potential to avert NCD death and disability. Our analysis highlights the need for implementation science studies to estimate the cost-effectiveness of integrated HIV-NCD screening and linkage per disability-adjusted life year and death averted.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/HIV testingCounselingNon-communicable diseaseSouth AfricaArticleJournal of Acquired Deficiency Syndrome